Free Trial

Recursion Pharmaceuticals (RXRX) Short Interest Ratio & Short Volume

Recursion Pharmaceuticals logo
$6.04 -0.23 (-3.67%)
(As of 11/20/2024 ET)

Recursion Pharmaceuticals Short Interest Data

Recursion Pharmaceuticals (RXRX) has a short interest of 62.43 million shares, representing 27.97% of the float (the number of shares available for trading by the public). This marks a 5.03% increase in short interest from the previous month. The short interest ratio (days to cover) is 12.7, indicating that it would take 12.7 days of the average trading volume of 6.19 million shares to cover all short positions.

Current Short Interest
62,430,000 shares
Previous Short Interest
59,440,000 shares
Change Vs. Previous Month
+5.03%
Dollar Volume Sold Short
$394.56 million
Short Interest Ratio
12.7 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
286,640,000 shares
Float Size
223,170,000 shares
Short Percent of Float
27.97%
Today's Trading Volume
16,994,717 shares
Average Trading Volume
6,194,816 shares
Today's Volume Vs. Average
274%
Short Selling Recursion Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RXRX Short Interest Over Time

RXRX Days to Cover Over Time

RXRX Percentage of Float Shorted Over Time

Recursion Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202462,430,000 shares $394.56 million +5.0%28.0%12.7 $6.32
10/15/202459,440,000 shares $396.46 million -5.0%26.2%12.2 $6.67
9/30/202462,580,000 shares $412.40 million +5.8%27.9%12.3 $6.59
9/15/202459,160,000 shares $388.68 million +5.6%26.5%10.2 $6.57
8/31/202456,030,000 shares $407.90 million +3.5%26.0%9.9 $7.28
8/15/202454,150,000 shares $362.26 million +7.5%25.1%9.6 $6.69
7/31/202450,370,000 shares $413.03 million +2.1%24.7%8.8 $8.20
7/15/202449,330,000 shares $404.51 million +9.8%24.8%8.9 $8.20
6/30/202444,920,000 shares $336.90 million 0.0%23.6%8.5 $7.50
6/15/202444,930,000 shares $416.05 million +3.0%26.5%9.6 $9.26
5/31/202443,640,000 shares $361.34 million +3.0%26.7%8.6 $8.28
5/15/202442,370,000 shares $424.12 million +4.6%26.1%7.3 $10.01
4/30/202440,500,000 shares $316.71 million +4.7%25.0%6.5 $7.82
4/15/202438,700,000 shares $301.47 million -2.7%26.4%6.2 $7.79
3/31/202439,760,000 shares $396.41 million -8.6%27.1%5.7 $9.97
3/15/202443,520,000 shares $488.29 million +1.6%29.7%6.2 $11.22
2/29/202442,820,000 shares $576.36 million +12.0%29.2%6.4 $13.46
2/15/202438,240,000 shares $475.32 million -0.1%26.1%6 $12.43
1/31/202438,270,000 shares $360.12 million +0.5%25.2%7.1 $9.41
1/15/202438,090,000 shares $425.08 million +2.8%25.1%7.3 $11.16
12/31/202337,040,000 shares $365.21 million +0.1%24.4%8.1 $9.86
12/15/202337,020,000 shares $359.09 million +3.1%24.4%9.2 $9.70
11/30/202335,920,000 shares $246.05 million +1.2%23.9%9.1 $6.85
11/15/202335,500,000 shares $254.89 million +7.4%23.6%9.6 $7.18
10/31/202333,050,000 shares $174.50 million +3.8%23.9%9.3 $5.28
10/15/202331,850,000 shares $203.20 million +3.6%23.0%8.5 $6.38
9/30/202330,750,000 shares $235.24 million +26.3%22.2%4.6 $7.65
9/15/202324,340,000 shares $208.59 million +5.6%17.7%3.8 $8.57
8/31/202323,040,000 shares $200.45 million +11.8%17.6%3.8 $8.70
8/15/202320,610,000 shares $189.41 million +4.8%15.8%3.3 $9.19
7/31/202319,670,000 shares $277.74 million -0.3%16.6%3.4 $14.12
7/15/202319,720,000 shares $234.67 million +6.4%16.7%3.8 $11.90
6/30/202318,540,000 shares $138.49 million -5.0%15.7%8.9 $7.47
6/15/202319,520,000 shares $181.54 million +5.7%16.5%9.7 $9.30
5/31/202318,460,000 shares $161.89 million -7.7%15.8%9.9 $8.77
5/15/202320,000,000 shares $112 million -2.2%17.3%12.4 $5.60
4/30/202320,440,000 shares $97.50 million +2.2%17.8%18.4 $4.77
4/15/202320,000,000 shares $118.80 million +0.9%17.4%19.6 $5.94
3/31/202319,830,000 shares $132.27 million +4.3%17.3%20.3 $6.67
3/15/202319,020,000 shares $142.27 million +8.1%16.6%19 $7.48
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
2/28/202317,600,000 shares $143.44 million +1.7%15.4%16.4 $8.15
2/15/202317,310,000 shares $146.10 million -3.1%15.2%15.3 $8.44
1/31/202317,870,000 shares $148.86 million +2.2%16.7%14.4 $8.33
1/15/202317,480,000 shares $152.08 million +4.2%15.1%14 $8.70
12/30/202216,780,000 shares $129.37 million +17.8%14.4%13.9 $7.71
12/15/202214,240,000 shares $120.61 million -4.4%12.2%11.9 $8.47
11/30/202214,890,000 shares $139.97 million -0.2%13.5%11.9 $9.40
11/15/202214,920,000 shares $176.95 million -5.6%13.6%12.8 $11.86
10/31/202215,800,000 shares $166.69 million +1.6%19.3%14.1 $10.55
10/15/202215,550,000 shares $163.12 million -3.9%18.4%14.4 $10.49
9/30/202216,180,000 shares $172.16 million +12.4%19.2%14.8 $10.64
9/15/202214,390,000 shares $188.65 million -1.4%17.1%12.2 $13.11
8/31/202214,590,000 shares $153.34 million -7.6%17.4%14.3 $10.51
8/15/202215,790,000 shares $204.64 million -5.8%18.9%15.6 $12.96
7/31/202216,770,000 shares $141.87 million +4.9%20.2%16.6 $8.46
7/15/202215,990,000 shares $135.92 million +11.7%19.3%15.4 $8.50
6/30/202214,310,000 shares $116.48 million +3.0%17.3%13 $8.14
6/15/202213,890,000 shares $92.79 million -0.9%16.7%12.9 $6.68
5/31/202214,020,000 shares $85.80 million +3.4%17.1%12.5 $6.12
5/15/202213,560,000 shares $76.48 million -3.0%16.5%11.3 $5.64
4/30/202213,980,000 shares $86.68 million +0.4%17.1%12.1 $6.20
4/15/202213,920,000 shares $103.84 million -5.6%17.2%11.9 $7.46
3/31/202214,740,000 shares $105.54 million -8.2%16.9%12.7 $7.16
3/15/202216,060,000 shares $100.38 million -1.6%18.7%13.3 $6.25
2/28/202216,320,000 shares $178.70 million +5.0%19.0%11.1 $10.95
2/15/202215,550,000 shares $185.05 million +6.4%17.9%10.4 $11.90
1/31/202214,620,000 shares $173.10 million +5.6%16.7%9.3 $11.84
1/15/202213,840,000 shares $191.13 million +3.3%15.8%8.7 $13.81
12/31/202113,400,000 shares $229.54 million +20.8%15.3%8.5 $17.13
12/15/202111,090,000 shares $219.03 million +4.0%12.6%7.3 $19.75
11/30/202110,660,000 shares $203.82 million -2.8%12.8%9.4 $19.12
11/15/202110,970,000 shares $205.69 million -5.5%13.2%12 $18.75
10/29/202111,610,000 shares $222.33 million -10.8%14.0%15.7 $19.15
10/15/202113,010,000 shares $247.71 million +8.5%15.7%21.3 $19.04
9/30/202111,990,000 shares $275.89 million +31.9%14.5%24.4 $23.01
9/15/20219,090,000 shares $217.71 million +25.2%12.0%18.9 $23.95
8/31/20217,260,000 shares $183.10 million +19.0%9.6%16.5 $25.22
8/13/20216,100,000 shares $137.07 million No Change7.6%15.2 $22.47

RXRX Short Interest - Frequently Asked Questions

What is Recursion Pharmaceuticals' current short interest?

Short interest is the volume of Recursion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 62,430,000 shares of RXRX short. 27.97% of Recursion Pharmaceuticals' shares are currently sold short. Learn More on Recursion Pharmaceuticals' current short interest.

What is a good short interest ratio for Recursion Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RXRX shares currently have a short interest ratio of 13.0. Learn More on Recursion Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Recursion Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Recursion Pharmaceuticals: Jane Street Group LLC, and Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Recursion Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 27.97% of Recursion Pharmaceuticals' floating shares are currently sold short.

Is Recursion Pharmaceuticals' short interest increasing or decreasing?

Recursion Pharmaceuticals saw a increase in short interest in October. As of October 31st, there was short interest totaling 62,430,000 shares, an increase of 5.0% from the previous total of 59,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Recursion Pharmaceuticals' float size?

Recursion Pharmaceuticals currently has issued a total of 286,640,000 shares. Some of Recursion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Recursion Pharmaceuticals currently has a public float of 223,170,000 shares.

How does Recursion Pharmaceuticals' short interest compare to its competitors?

27.97% of Recursion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Recursion Pharmaceuticals: Schrödinger, Inc. (12.23%), Arcus Biosciences, Inc. (13.82%), Relay Therapeutics, Inc. (7.19%), AbCellera Biologics Inc. (8.04%), Exscientia plc (2.55%), Emergent BioSolutions Inc. (13.35%), Absci Co. (13.94%), Legend Biotech Co. (8.70%), Elanco Animal Health Incorporated (2.81%), Blueprint Medicines Co. (6.50%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Recursion Pharmaceuticals stock?

Short selling RXRX is an investing strategy that aims to generate trading profit from Recursion Pharmaceuticals as its price is falling. RXRX shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Recursion Pharmaceuticals?

A short squeeze for Recursion Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RXRX, which in turn drives the price of the stock up even further.

How often is Recursion Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXRX, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:RXRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners